Stocks and Investing Stocks and Investing
Tue, November 7, 2017
Mon, November 6, 2017
Fri, November 3, 2017
Thu, November 2, 2017

David Lewis Maintained (ZBH) at Buy with Decreased Target to $136 on, Nov 2nd, 2017


Published on 2024-10-26 00:23:42 - WOPRAI, David Lewis
  Print publication without navigation


David Lewis of Morgan Stanley, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Buy with Decreased Target from $146 to $136 on, Nov 2nd, 2017.

David has made no other calls on ZBH in the last 4 months.



There are 4 other peers that have a rating on ZBH. Out of the 4 peers that are also analyzing ZBH, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Kyle Rose of "Canaccord Genuity" Downgraded from Strong Buy to Hold on, Friday, July 28th, 2017


These are the ratings of the 3 analyists that currently disagree with David


  • Jennie Tsai of "Gabelli & Co." Initiated at Strong Buy on, Thursday, August 24th, 2017
  • Richard Newitter of "Leerink Swann" Maintained at Buy with Increased Target to $146 on, Friday, July 28th, 2017
  • Christopher Pasquale of "Guggenheim" Upgraded from Hold to Strong Buy on, Wednesday, July 12th, 2017